» Authors » Therese Y Andraos

Therese Y Andraos

Explore the profile of Therese Y Andraos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 105
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ladbury C, Sidiqi B, Cantrell N, Jones G, Skalina K, Fekrmandi F, et al.
Pract Radiat Oncol . 2024 Oct; PMID: 39424129
Purpose: Data informing the safety, efficacy, treatment logistics, and dosimetry of stereotactic body radiation therapy (SBRT) for lung tumors has primarily been derived from patients with favorably located solitary tumors....
2.
Daly S, Soto J, Gonzalez S, Ankrah N, Gogineni E, Andraos T, et al.
Clin Neurol Neurosurg . 2024 Sep; 246:108550. PMID: 39278006
Introduction: Medically refractory epilepsy (MRE) occurs in about 30 % of patients with epilepsy, and the treatment options available to them have evolved over time. The classic treatment for medial...
3.
Aziz K, Koffler D, Vassantachart A, Rattani A, Ankrah N, Gogineni E, et al.
Pract Radiat Oncol . 2024 Sep; 15(1):54-68. PMID: 39233007
Purpose: Spinal stereotactic body radiation therapy (SBRT) has become the standard of care in management of patients with limited sites of metastatic disease, radioresistant histologies, painful vertebral metastases with long...
4.
Vassantachart A, Ehret F, Chen E, Kumar R, Gogineni E, Andraos T, et al.
Pract Radiat Oncol . 2024 Jul; 14(6):499-511. PMID: 38970567
Purpose: Meningiomas represent the most common primary tumor of the central nervous system. Current treatment options include surgical resection with or without adjuvant radiation therapy (RT), definitive RT, and observation....
5.
Ladbury C, Sueyoshi M, Brovold N, Kumar R, Andraos T, Gogineni E, et al.
Pract Radiat Oncol . 2023 Oct; 14(3):252-266. PMID: 37875223
Purpose: The use of stereotactic body radiation therapy (SBRT) for gynecologic malignancies is controversial. We discuss certain circumstances when highly precise SBRT may be a useful tool to consider in...
6.
Ayoub Z, Khader J, Bulbul M, Khauli R, Andraos T, Shamseddine A, et al.
BMC Urol . 2022 Dec; 22(1):204. PMID: 36503556
Background: A nadir Prostate-Specific Antigen (nPSA) of 0.06 ng/mL has been shown to be a strong independent predictor of biochemical recurrence-free survival (bRFS) in patients with intermediate or high-risk (HR)...
7.
Andraos T, Halmos B, Cheng H, Huntzinger C, Shirvani S, Ohri N
Clin Lung Cancer . 2022 Apr; 23(4):291-299. PMID: 35382980
Background: First-line immunotherapy (IMT), with or without cytotoxic chemotherapy, is now recommended for most patients with advanced non-small cell lung cancer (NSCLC) with no targetable mutations. We reviewed outcomes for...
8.
Andraos T, Ayoub Z, Nastoupil L, Milgrom S, Pinnix C, Ng S, et al.
Leuk Lymphoma . 2019 Jun; 60(13):3258-3265. PMID: 31234671
Patients with early-stage nodal follicular lymphoma (FL) may be rendered free of detectable disease by a diagnostic excisional biopsy. We reviewed the management and outcomes of 48 patients with FL,...
9.
An Y, Jiang W, Andraos T, Reddy J, Yehia Z, Lloyd S, et al.
Radiother Oncol . 2019 Feb; 131:88-92. PMID: 30773193
Background And Purpose: A lower proportion of CD8+ tumor infiltrating lymphocytes in mycosis fungoides (MF) patients is associated with worse survival. However, it is not known whether circulating CD4:CD8 ratio...
10.
Sheu T, Milgrom S, Andraos T, Gunther J, Chi L, Nastoupil L, et al.
Adv Radiat Oncol . 2018 Oct; 3(4):639-646. PMID: 30370365
Background: For patients with primary diffuse large B-cell lymphoma of the central nervous system (PCNSL), whole-brain radiation therapy (WBRT) to doses of ≥45 Gy are often given after a partial...